MiR-92 overexpression suppresses immune cell function in ovarian cancer via LATS2/YAP1/PD-L1 pathway

S Feng1, H Sun1, W Zhu2

  • 1Department of Gynecology and Obstetrics, The Second Affiliated Hospital of Soochow University, 1055 Sanxiang Road, Suzhou, 215004, Jiangsu Province, People's Republic of China.

Abstract

Insights

MicroRNA-92 (miR-92) is overexpressed in ovarian cancer, promoting tumor growth and immune suppression by targeting LATS2, leading to increased PD-L1 and reduced NK cell function.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • MicroRNAs (miRNAs) are critical regulators in various cancers, including ovarian cancer.
  • Dysregulation of miRNA expression is implicated in ovarian cancer pathogenesis and progression.

Purpose of the Study:

  • To investigate the role of microRNA-92 (miR-92) in ovarian cancer.
  • To elucidate the underlying molecular mechanisms by which miR-92 influences ovarian cancer progression and immune evasion.

Main Methods:

  • Quantitative analysis of miR-92 expression in clinical ovarian cancer tissues.
  • In vitro functional assays to assess the impact of miR-92 on cancer cell proliferation, migration, and colony formation.
  • Molecular mechanism studies using luciferase assays, co-immunoprecipitation (Co-IP), and chromatin immunoprecipitation (ChIP) to identify miR-92 targets and downstream pathways.

Main Results:

  • miR-92 is significantly overexpressed in ovarian cancer tissues compared to normal tissues.
  • miR-92 promotes ovarian cancer cell proliferation, migration, and colony formation.
  • miR-92 directly targets LATS2, leading to its downregulation.
  • Downregulation of LATS2 results in YAP1 translocation, PD-L1 upregulation, and subsequent suppression of Natural Killer (NK) cell function and promotion of T cell apoptosis.
  • YAP1 binds to the enhancer region of PD-L1, enhancing its transcription.

Conclusions:

  • miR-92 plays a crucial oncogenic role in ovarian cancer.
  • A novel mechanism involving miR-92, LATS2, YAP1, and PD-L1 contributes to immune suppression in ovarian cancer.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K